Publications scientifiques sur les diagnostics non invasifs BioPredictive

Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.

Akuta N et al. · J Gastroenterol · 2018 Score 100

…12 weeks with fixed-dose daclatasvir, asunaprevir, and beclabuvir (DCV-TRIO). As…

FibroTest HCV

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. Review

Afdhal NH et al. · J Viral Hepat · 2013 Score 93

Emerging data indicate that all-oral antiviral treatments for chronic hepatitis C…

ActiTest FibroTest HCV

Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis.

Asselah T et al. · Liver Int · 2018 Score 86

### Background & Aims Patients with chronic hepatitis C virus infection and advanced fibrosis…

FibroTest HCV

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Key publication

AASLD/IDSA HCV Guidance Panel · Hepatology · 2015 Score 79

ActiTest FibroTest HCV

Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters? Review

Gentile I et al. · Infez Med · 2014 Score 72

It is estimated that hepatitis C virus (HCV) infects chronically about 160…

FibroTest HCV

Prise en charge des personnes infectées par les virus de l’hépatite B ou de l’hépatite C — Rapport de recommandations 2014 Key publication

Score 65

FibroTest HBV HCV

Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection Key publication

· 2014 Score 58

These are the first guidelines dealing with hepatitis C treatment produced by…

FibroTest HCV